Biotech · Private company
Blaze Bioscience Inc.
Track this companyFree. Adds Blaze Bioscience Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials40 recruiting or active
Pipeline programs3From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline3
- Canvas SystemPhase 3 · Pediatric Central Nervous System TumorClinicalTrials.gov · fetched Nov 12, 2026
- tozuleristidePhase 3 · Pediatric Central Nervous System TumorClinicalTrials.gov · fetched Nov 12, 2026
- BLZ-100Phase 1 · Central Nervous System TumorsClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials4
- A Fluorescent Tumor Marking Agent, Tozuleristide, for Imaging Oral Cavity Squamous Cell Cancer and High-Grade Oral Cavity Dysplasia During SurgeryPHASE1_PHASE2 · TERMINATED · started Apr 17, 2024ClinicalTrials.gov NCT05316688 · fetched Nov 12, 2026
- Fluorescence Detection of Adult Primary Central Nervous System Tumors With Tozuleristide and the Canvas SystemPHASE2 · COMPLETED · started Sep 30, 2021ClinicalTrials.gov NCT04743310 · fetched Nov 12, 2026
- Study of Tozuleristide and the Canvas Imaging System in Pediatric Subjects With CNS Tumors Undergoing SurgeryPHASE2_PHASE3 · COMPLETED · started Nov 26, 2018ClinicalTrials.gov NCT03579602 · fetched Nov 12, 2026
- Study of BLZ-100 in Pediatric Subjects With CNS TumorsPHASE1 · COMPLETED · started Jun 1, 2015ClinicalTrials.gov NCT02462629 · fetched Nov 12, 2026